BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $30.1K in total
- 9
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 21
- 13F valueReported value at the end of Q2 2026
- $1.65M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BCDA, Q2 2026
No superinvestor reported holding BCDA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BioCardia, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)8:14 PM ET | Sep 23 | Same day | Altman PeterPresident and CEO | PPurchase | +1.90K | $1.05 | +$2.00K | +0.5%383.9K after | |
| Sep 4, 2026 (view filing)9:30 PM ET | Sep 3 | 1 day | Altman PeterPresident and CEO | PPurchase | +800 | $1.09 | +$872 | +0.2%382.0K after | |
| Aug 18, 2026 (view filing)12:14 PM ET | Aug 17 | 1 day | Altman PeterPresident and CEO | PPurchase | +5.40K | $0.93 | +$5.02K | +1.4%381.1K after | |
| Aug 13, 2026 (view filing)5:43 PM ET | Aug 13 | Same day | Altman PeterPresident and CEO | PPurchase | +1.90K | $0.92 | +$1.75K | +0.5%375.8K after | |
| Jul 29, 2026 (view filing)9:05 PM ET | Jul 29 | Same day | Altman PeterPresident and CEO | PPurchase | +5.00K | $0.78 | +$3.90K | +1.4%373.9K after | |
| Jul 20, 2026 (view filing)4:16 PM ET | Jul 17 | 3 days | Altman PeterPresident and CEO | PPurchase | +500 | $0.83 | +$415 | +0.1%368.9K after | |
| Jul 15, 2026 (view filing)4:40 PM ET | Jul 14-15 | 1 day | Altman PeterPresident and CEO | PPurchase | +4.30K | $0.873 | +$3.75K | +1.2%368.4K after | 2 lots |
| Jul 10, 2026 (view filing)6:18 PM ET | Jul 8-10 | 2 days | Altman PeterPresident and CEO | PPurchase | +7.50K | $0.9567 | +$7.17K | +2.1%369.5K after | 3 lots |
| Jul 8, 2026 (view filing)3:30 PM ET | Jul 8 | Same day | Altman PeterPresident and CEO | PPurchase | +5.40K | $0.9645 | +$5.21K | +1.5%362.0K after | |
| Jun 24, 2026 (view filing) | Jun 22-23 | 2 days | Stertzer Simon HDirector | PPurchase | +109.2K | $0.9486 | +$103.6K | +191.1%166.3K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in BioCardia, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 397,594 | $493.0K | 0.00% | +397,594 | New |
| CM Management, LLC | 300,000 | $372.0K | 0.24% | +170,000+130.8% | Added |
| Vanguard Capital Management LLC | 124,591 | $154.5K | 0.00% | 00.0% | Unchanged |
| Pingora Partners LLC | 120,382 | $149.3K | 0.09% | +84,643+236.8% | Added |
| UBS Group AG | 77,619 | $96.2K | 0.00% | +77,619 | New |
| Geode Capital Management, LLC | 66,664 | $82.7K | 0.00% | −27,623−29.3% | Reduced |
| Vanguard Fiduciary Trust Co | 66,270 | $82.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 38,809 | $48.1K | 0.00% | −180.0% | Reduced |
| Brown Advisory Inc | 35,538 | $44.1K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 23,383 | $29.0K | 0.00% | +5,100+27.9% | Added |